AMF Tjänstepension’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,179
Closed -$5.51M 222
2023
Q2
$5.51M Sell
25,179
-28,872
-53% -$6.43M 0.05% 185
2023
Q1
$11.8M Sell
54,051
-11,027
-17% -$2.39M 0.12% 122
2022
Q4
$13.5M Hold
65,078
0.16% 114
2022
Q3
$14.2M Sell
65,078
-18,466
-22% -$4.2M 0.17% 103
2022
Q2
$17.5M Sell
83,544
-1,373
-2% -$292K 0.17% 100
2022
Q1
$20.6M Hold
84,917
0.15% 123
2021
Q4
$22.1M Sell
84,917
-5,207
-6% -$1.35M 0.15% 129
2021
Q3
$23.8M Sell
90,124
-11,265
-11% -$3.08M 0.17% 128
2021
Q2
$25M Hold
101,389
0.17% 128
2021
Q1
$19.7M Hold
101,389
0.15% 144
2020
Q4
$21.6M Sell
101,389
-6,316
-6% -$1.26M 0.18% 118
2020
Q3
$18.5M Buy
+107,705
New +$19.9M 0.17% 127

Other funds holding RMD

AMF Tjänstepension's RMD Position: Q3 2023 in Review

AMF Tjänstepension sold out of ResMed (RMD) in Q3 2023, closing a stake of 25,179 shares — an estimated $5.51M sold.

AMF Tjänstepension first reported a position in RMD in Q3 2020 and held it in 12 quarters. The position peaked at $25M in Q2 2021. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • AMF Tjänstepension reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • AMF Tjänstepension sold 25,179 ResMed shares in Q3 2023, an estimated $5.51M.
  • AMF Tjänstepension first reported a position in ResMed in Q3 2020 and held it in 12 quarters.
  • AMF Tjänstepension's ResMed position peaked at $25M in Q2 2021.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on AMF Tjänstepension's 13F filing for Q3 2023, filed 26 Oct 2023.